In an attempt for development of new antimicrobial agents; new series of chromen-2-one, pyrano [3,4-c]chromene and pyridino [3,4-c]chromene derivatives bearing a diazo moiety were synthesized. Chromen-2-one derivatives were synthesized via treatment of 5-(aryldiazo) salicylaldehyde with different type of active methylene derivatives. Pyrano[3,4-c]chromene and pyridino[3,4-c]chromene derivatives were synthesized via treatment of chromen-2-one derivatives with another active methylene derivatives. The synthesized compounds were evaluated for their expected antimicrobial activity; where, the majority of these compounds showed potent antibacterial and antifungal activities against the tested strains of bacteria and fungi.
INTRODUCTION
ATURAL and synthetic chromen-2-one derivatives have great interest from medicinal chemists, many of the chromene derivatives used as precursors for the synthesis of potentially biologically active compounds. [1] [2] [3] [4] [5] Chromen-2-one moiety is being the parent scaffold in many of biological derivatives. Some of chromene skeleton are well established as antimicrobial agents such as Novobiocin and Chlorobiocin. [6] Recently, chromene derivatives have great interesting due to their potential application such as anti-HIV, [7] antitubercular, [8] antioxidant, [9] anticancer, [10] cytotoxic agents, [11] antidyslipidemic agent, [12] antileishmanial, [13] anti-inflammatory agents. [14] Diazo compounds showed many valuable medicinal and pharmaceutical activities such as inhibition of RNA, DNA and carcinogenesis, protein synthesis and nitrogen fixation. [15] [16] [17] [18] Bacterial and fungal resistance is one of the serious medical problems. Also, the levels rate of resistance is increasing to classical antibiotics. So, the development and discovery of effective antibacterial and antifungal drugs with novel mechanisms of action become urgent tasks for antimicrobial research programs. [19] [20] [21] [22] In light of these facts, the present study was designed to synthesize new chromene derivatives and evaluate their antimicrobial activity. As a trial to obtain novel class of antibacterial and antifungal agents, various groups were introduced into the target compounds
RESULTS AND DISCUSSION

Chemistry
Treatment salicylaldehyde derivative 1 [23] with ethyl acetoacetate in boiling EtOH/DMF led to the formation of chromen-2-one derivative 2 as yellow solid in high yield (Scheme 1). Its IR spectrum showed absorption bands at: 1740, 1650 cm -1 corresponding to 2C=O functional groups. 1 H NMR revealed signals at: δ = 2.86 and 8.87 ppm corresponding to CH3 and chromene-H4, respectively. In addition, the resulting chromene derivative was used for further chemical transformations as new routes for condensed chromene with possible biological activity. Acetylcoumarin derivative 2 was allowed to react with cyanoacetamide in presence of a catalytic amount of piperidine to give pyrano [3,4-c] chromene derivative 3. IR spectrum of compound 3 revealed absorption bands at: δ = 3413 and 2209 cm -1 for the OH and cyano functional groups. Its 1 H NMR spectrum showed two characterized signals at: δ = 2.50 and δ = 9.04 ppm assigned for the CH3 and OH protons.
Reaction of acetylcoumarin derivative 2 with 2-cyano-N-(furan-2-ylmethyl) acetamide [24] in the presence of few drops of piperidine under reflux yielded the corresponding pyrano [3,4- c]chromene derivative 4. IR spectrum of 4 showed absorption bands at: 3253, 2209 and 1709 cm -1 corresponding to NH, C≡N and C=O functional groups, respectively. 1 H NMR spectrum showed three signals at: δ = 2.57, 3.9 and 5.07 ppm due to CH3, CH2, and CH protons, respectively. Formation of 4 may be proceed through the addition of methylene group to the activated double bond of chromene to give Michael adduct, which cyclized to the respective pyrano [3,4- c]chromene 4 as a final product via elimination of water molecule.
Interaction of 1 with malononitrile in the presence of piperidine, 3-cyano chromane derivative 5 was obtained in good yield (Scheme 2). Its IR spectrum showed two characterized absorption bands at: 3348 and 2210 cm -1 corresponding to NH and C≡N functional groups, respectively. Also, its 1 H NMR assigned multiple signals in the region 7.54-8.25 for Ar-H with H-pyrane. In addition, interaction of compound 5 with malononitrile or ethyl acetoacetate in presence of catalytic amount piperidine afforded chromenylmalononitrile derivative 6 and chromenyl ethyl cyanoacetate derivative 7, respectively. Chromenylmalononitrile 6 can be prepared by treatment compound 1 with two moles of malononitrile. IR spectrum of 7 revealed the presence of cyano and carbonyl ester functional groups at: 2203 and 1737 cm -1 , respectively. Its 1 H NMR spectrum displayed in addition to the aromatic proton signals, two doubles signals at: δ = 3.93 and 4.16 ppm integrated for two protons due to the two CH protons. Moreover, its 13 C NMR confirmed the structure.
Cyclocondensation of the salicylaldehyde derivative 1 with diethyl malonate in presence of piperidine as catalyst afforded chromene-3-carboxylate derivative 8 as colored solid in high yield (Scheme 3). IR spectrum of 8 revealed absorption band at: 1722 cm -1 attributed for C=O functional group. 1 H NMR spectrum was characterized by the presence of triplet and quartet signals at: δ = 1.20 and 4.29 ppm corresponding for ethyl protons. Iminochromene derivatives 9a and 9b were obtained through cyclocondensation of 1 with 2-cyano-N-(cyclohexyl)acetamide [25] and 2-cyano-N-(furan-3-ylmethyl)acetamide, respectively. IR spectrum of 9a exhibited strong absorption bands at 3338 and 1672 cm -1 due to NH and C=O functional groups, respectively. Its 1 H NMR showed signals at: δ = 0.80-1.06, 2.65-2.71, 8.96 and 10.17 ppm corresponding to CH2 cyclohexyl, CH-N cyclohexyl, NH and CONH protons, respectively.
On the same manner, interaction of 1 with 2-cyano-N'-(4-methoxybenzylidene)acetohydrazide afforded the corresponding iminochromene derivative 10. IR spectrum of 10 showed bands for amino and carbonyl groups at: 3301 and 1660 cm -1 , respectively. 1 H NMR spectrum displayed two characterized singlet signals at: δ = 3.80 and 8.75 ppm corresponding for OCH3 and azomethine protons, respectively. In addition, 13 C NMR showed three signals at: 55.8, 151.0 and 160.9 corresponding to OCH3, C=N and C=O carbons, respectively.
In addition, chromene-3-carboxamide 11 was obtained via interaction of 1 with cyanoacetamide in EtOH/ DMF containing catalytic amount of piperidine. 1 H NMR spectrum of 11 afforded two broad signals at: δ = 8.62, 9.04 ppm attributed to NH and NH2 protons. Reaction of chromene derivative 11 with malononitrile or acetylacetone afforded products which formulated on the basis of elemental analysis and spectral data as chromenopyridine derivatives 12 and 13, respectively (Scheme 4). 1 H NMR spectrum of 12 exhibited two broad signals at: δ = 4.31 and 9.54 ppm due to NH2 and NH protons, respectively. 1 H NMR spectrum of 13 exhibited signals at: δ = 2.27, 2.47 and 8.70 ppm corresponding to CH3, COCH3 and NH protons, respectively. The formation of 12 and 13 is assumed through the Michael addition of the activated methylene group to the activated double bond in compound 11 to afford the acyclic Michael adduct that cyclized, then aromatized to yield the final products.
Finally, 2-iminochromene derivative 9b was utilized as a starting material for further reaction. Hence, reaction of 9b with malononitrile or ethyl cyanoacetate in presence of a catalytic amount of piperidine afforded pyridino [3,4- (RCMB02593), Candida albicans (RCMB 05035), and Penicillium marneffei (RCMB 01267). Agar-diffusion method [26] was used for the determination of the preliminary screening of antibacterial activity. The newly synthesized target compounds were evaluated against clinical isolates of standard strains of fungi by the broth dilution method according to NCCLs [27] Ampicillin, Gentamycin and Amphotericin B were used as reference drugs for Gram-positive bacteria, Gram-negative bacteria and fungi, respectively. The results were recorded for each tested compounds as the average diameter of inhibition zones of bacterial growth around the discs in mm. The inhibition zone diameters, attributed to the tested original concentration (5 mg/mL) as a preliminary test, are shown in Table 1 .
Concerning the antimicrobial activity of chromene derivatives 2, 5, 8, 9a,b, 10, 11, the results displayed those derivatives showed moderate to good activities against most of all the screened organisms. Using the general structure provided in Figure 1 , certain aspects of the structure activity relationships for these compounds can be more clearly highlighted.
The results revealed that compound 2 showed antimicrobial activity nearly equipotent to the reference drug against all screened organisms. While compound 8 showed antimicrobial activity nearly equipotent to the reference drug only against gram -ve bacteria. Chromen-2-one 5, 9a,b, 10 and 11; X was NH group and R were cyano or carboxamide derivatives. Regarding the effect of R group, compound 5 showed high antimicrobial activity against all screened organisms. Compound 9b and 10 showed good antimicrobial activities only against gram +ve bacteria. Compound 11 showed high antimicrobial activity only against gram -ve bacteria. Compound 9a showed high antimicrobial activity only against fungi. Using the general structure provided in Figure 1 , compound 6 showed high antimicrobial activity against all screened bacteria while compound 7 showed good activity only against fungi.
Using the general structure provided in Figure Figure 3 .
MINIMUM INHIBITORY CONCENTRATIONS AGAINST GRAM POSITIVE BACTERIA, GRAM NEGATIVE BACTERIA
AND FUNGI The minimal inhibitory concentrations (MICs) for the promising compounds were determined using twofold serial dilution method [27] MICs results (µg/mL) of the most promising derivatives 2, 3, 5, 6, 9a, and 11-15 are presented in Table 2 . The majority of synthesized compounds showed varying degrees of inhibition against the test panel of species.
Pyridino[3,4-c]chromene 14 showed equipotent potency of standard drugs in inhibiting the growth of S. pyogenes (MIC 0.24 μg/mL), P. vulgaris (MIC 1.95 μg/mL), S. flexneri (MIC 0.48 μg/mL), A. clavatus (MIC 1.95 μg/mL) and P. Marneffei (MIC 1.95 μg/mL). Pyridino[3,4-c]-chromene 14 displayed 50 % less activity compared to standard drugs against P. aeruginosa (MIC 62.5 μg/mL).
Chromen-2-one 11 showed equipotent potency of standard drugs in inhibiting the growth of S. flexneri (MIC 0.48 μg/mL), P. aeruginosa (MIC 31.25 μg/mL) and P. Marneffei (MIC 1.95 μg/mL). Chromen-2-one 11 displayed 50 % less activity compared to standard drugs against S. pyogenes (MIC 0.48 μg/mL), P. vulgaris (MIC 3.9 μg/mL), A. Fumigates (MIC 1.95 μg/mL), A. clavatus (MIC 3.9 μg/mL) and C. albicans (MIC 0.48 μg/mL). Chromen-2-one 9a showed equipotent potency of standard drugs in inhibiting the growth of A. fumigates (MIC 0.97 μg/mL). Chromen-2-one derivative 9a displayed 50 % less activity compared to standard drugs against S. pyogenes (MIC 0.48 μg/mL), P. vulgaris (MIC 3.9 μg/mL), P. aeruginosa (MIC 62.5 μg/mL), A. clavatus (MIC 3.9 μg/mL), C. albicans (MIC 0.48 μg/mL) and P. Marneffei (MIC 3.9 μg/mL).
Chromene 5 displayed 50 % less activity compared to standard drugs against S. epidermidis (MIC 0.24 μg/mL), P. vulgaris (MIC 3.9 μg/mL), K. pneumonia (MIC 0.48 μg/mL), A. clavatus (MIC 3.9 μg/mL) and P. Marneffei (MIC 3.9 μg/mL).
Chromene 2 displayed 50 % less activity compared to standard drugs against P. vulgaris (MIC 3.9 μg/mL) and P. Marneffei (MIC 3.9 μg/mL).T2 
Experimental Section
All melting points are recorded on digital Gallen Kamp MFB-595 instrument and may be uncorrected. The IR spectra (KBr) (cm -1 ) were measured on a JASCO spectrophotometer. 1 H NMR spectra were recorded on Bruker spectrometers (at 500 MHz) and are reported relative to deuterated solvent signals in deuterated dimethylsulfoxide (DMSO-d6). 13 C NMR spectra were recorded on Bruker Spectrometers (at 125 MHz) in deuterated dimethylsulfoxide (DMSO-d6). The purity of the synthesized compounds was monitored by TLC. Elemental analyses were carried out by the Microanalytical Research Center, Faculty of Science, Cairo University. Analytical results for C, H and N were within -/+ 0.4 of the calculated values. The antimicrobial screening and minimal inhibitory concentrations of the tested compounds were carried out at the Regional Center for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt. 
SYNTHESIS OF 3-ACETYL-6-((4-CHLOROPHENYL)-DIAZENYL)-2H-CHROMEN-2-ONE (2)
Equimolar
SYNTHESIS OF 9-((4-CHLOROPHENYL)DIAZENYL)-2-(FURAN-2-YLMETHYLAMINO)-4-METHYL-5-OXO-5,10b-DIHYDROPYRANO[3,4-c]CHROMENE-1-CARBONITRILE (4)
A mixture of 2 (0.01 mol) and 2-cyano-N-(furan-2-ylmethyl) acetamide (0.01 mol) in a mixture of 15 mL EtOH and 5 mL DMF containing a catalytic amount of piperidine was heated under reflux for 4 h, then left to cool. The solid product formed was filtrated off, washed with EtOH, dried, 
SYNTHESIS OF 6-((4-CHLOROPHENYL)DIAZENYL)-2-IMINO-2H-CHROMENE-3-CARBONITRILE (5)
A
SYNTHESIS OF 2-(6-((4-CHLOROPHENYL)DIAZENYL)-3-CYANO-2-IMINO-2H-CHROMEN-4-YL)MALONONITRILE (6)
Method
SYNTHESIS OF ETHYL 2-(2-AMINO-6-((4-CHLORO-PHENYL)DIAZENYL)-3-CYANO-4H-CHROMEN-4-YL)-2-CYANOACETATE (7)
SYNTHESIS OF 6-((4-CHLOROPHENYL)DIAZENYL)-2-IMINO-2H-CHROMENE-3-CARBOXAMIDE (11)
SYNTHESIS OF 2-AMINO-9-((4-CHLOROPHENYL)-DIAZENYL)-5-IMINO-4-OXO-4,5-DIHYDRO-3H-CHROMENO[3,4-C]PYRIDINE-1-CARBONITRILE (12)
A mixture of 11 (0.01 mol) and malononitrile (0.01 mol) in 20 mL EtOH/DMF (3/1) was heated under reflux for 4 h, then cooled and poured into ice water. The resulting solid was filtered off, washed with water, dried and purified by recrystallization from ethanol to give compound 12 as red crystals. Yield 50 %; m.p. >300 °C; IR: ν/cm - 
SYNTHESIS OF 1-ACETYL-9-((4-
CHLOROPHENYL
